Deep Health AI India Limited

Deep Health AI India Limited

BBSE:DEEPAI
1.63
INR
-0.05
(-2.98%)
273.89MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.93
0.34
0.95
0.48
0.36
0.23
0.15
0.4
1.47
0.49
0.24
0.42
- -
Basic EPS, GAAP
0.04
-0.02
0.02
-0.01
-0.01
-0.01
-0.01
0.06
0.24
0.08
0.17
0.11
- -
Free Cash Flow per Basic Share
-0.12
-0.05
0.02
-0.2
-0.07
-0.08
-0.04
14.96
- -
-1.04
0.26
-0.36
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.2
0.14
- -
Book Value per Share
2.2
2.18
2.21
2.21
2.19
2.16
2.16
2.22
2.83
3.92
4.29
3.56
- -
Tangible Book Value per Share
2.2
2.18
2.21
2.21
2.19
2.16
2.16
2.22
2.83
3.92
4.29
3.56
- -
Basic Weighted Avg Shares
34
35
35
35
35
35
35
35
52
52
52
102
144
Sales/Revenue/Turnover
31
12
33
17
13
8
5
14
77
26
13
43
- -
Operating Margin (%)
3.84
-23.28
-0.19
-18.43
-23.99
-39.85
-48.38
0.08
21.05
31.41
35.34
78.32
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
1
-1
1
- -
- -
- -
- -
2
13
4
9
11
- -
Effective Tax Rate (%)
32.02
- -
25.09
- -
- -
- -
619.23
25.51
27.52
28.38
21.34
29.01
- -
Profit Margin (%)
4.73
-6.13
2.14
-1.11
-1.74
-3.45
-9.18
14.15
16.37
16.31
69.61
26.68
- -
Working Capital
71
71
72
42
39
37
41
46
47
32
33
131
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
76
76
76
76
76
75
75
77
147
204
223
514
- -
Return on Invested Capital (%)
- -
- -
0.92
- -
- -
- -
15.86
0.01
8.82
-0.91
1.55
-4.19
- -
Return on Capital (%)
- -
- -
0.93
- -
- -
- -
-0.63
2.6
10.16
2.81
4.13
3.09
- -
Return on Common Equity (%)
- -
-0.95
0.93
-0.24
-0.29
-0.37
-0.63
2.6
11.21
2.37
4.1
3.08
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
4
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
145
144
143
Market Capitalization
- -
274
317

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
138
- -
Cash, Cash Equivalents & STI
- -
92
- -
Accounts Receivable, Net
- -
29
- -
Inventories
- -
5
- -
Total Current Liabilities
- -
7
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
4
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
27.15%
54.48%
129.96%
Free Cash Flow
-6,408.39%
-12,568.54%
-372.7%
Net Income, GAAP
-11.97%
18.05%
29.37%
Sales/Revenue/Turnover
77.75%
148.71%
237.55%
Total Cash Common Dividend
- -
- -
36.49%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
5
3
- -
5
13
2026
2
- -
5
3
43
2027
5
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.06
0.04
0.01
0.07
0.17
2026
0.01
- -
0.21
-0.31
0.11
2027
-0.15
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.2
2026
- -
- -
- -
- -
0.14
2027
- -
- -
- -
- -
- -

Company Description

CEO
Narayan Singh Rathore
Full Time Employees
6
Sector
Retail trade
Industry
Specialty stores
Address
309, V Star Plaza Udaipur India
IPO Date
Jan 12, 2016
Business
Deep Diamond India Limited, established in Mumbai in 1994, originally focused on crafting and distributing gold and diamond-studded jewelry. The company's offerings spanned a variety of pieces, including pendants, rings, bangles, and necklace sets, alongside trading loose diamonds and gold frames. Expanding its operational scope, the firm diversified into the pharmaceutical sector in 2023, engaging in the development and marketing of a range of innovative drugs, therapies, and medical devices, while also offering consultancy services to the industry. Most recently, in November 2025, Deep Diamond India announced its entry into preventive healthcare with the launch of "Deep Health India AI," a digital platform utilizing facial-scan technology to deliver real-time health insights.